Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person said. Bain Capital has been riding a growing wave of Japanese mergers and acquisitions in ...

HONG KONG] Bain Capital is looking to raise billions of US dollars for its next Asia fund and a special situation fund in the region, as it moves to back private equity (PE) and credit deals in ...

Bain Capital LP has entered into a definitive agreement with ... Following the closing of the transaction, Tanabe Pharma will continue to develop innovative medical technologies to enhance research ...

JERSEY CITY, N.J., April 3, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced 11 presentations will be shared at the American Academy of Neurology (AAN) 2025 Annual ...

"These findings help build upon our understanding of edaravone's potential effects in ALS," said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs at MTPA. "By modulating TDP-43 ...

Mumbai: Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure Pharmaceuticals Ltd through a substantial block deal, according to two ...

Packaging and storage are crucial in pharma supply chains. Businesses in the segment have attracted several PE firms, including 1315 Capital ... have some insights by Bain & Company on the ...

Bain Capital will buy 18 per cent stake in Kerala-based gold loan financier Manappuram Finance for ₹4,385. The deal has triggered an open offer where Bain will buy an extra 26 per cent stake ...

Wednesday announced an $825 million strategic growth investment from Bain Capital for a 9.9% stake in the company.

The investment, executed through Bain Capital affiliates BC Asia Investments XXV Limited and BC Asia Investments XIV Limited, will be undertaken in partnership with the existing promoters, who will ...